Cloned (Comment) | Organism |
---|---|
gene yfmK, recombinant expression of wild-type and mutant enzymes in Escherichia coli strain BL21(DE3) | Bacillus subtilis |
Protein Variants | Comment | Organism |
---|---|---|
F124A | site-directed mutagenesis | Bacillus subtilis |
F129A | site-directed mutagenesis | Bacillus subtilis |
G88A | site-directed mutagenesis, yfmKG88A is found to phenocopy the yfmK mutant most closely in vivo. HbsK41Q is able to bypass the yfmKG88A phenotype, suggesting that the cognate protein is catalytically inactive | Bacillus subtilis |
additional information | generation of mutations that mimic the acetylated and unacetylated forms of the protein, resulting in the inability to acetylate key HBsu lysine residues leading to a more compacted nucleoid | Bacillus subtilis |
Y89A | site-directed mutagenesis | Bacillus subtilis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-CoA + [HBsu]-L-lysine | Bacillus subtilis | essential histone-like protein HBsu contains seven acetylation sites in vivo, mutational analysis using mutants hbsK86Q, hbsK41Q, hbsK3Q, hbsK41R, and hbsK37R | CoA + [HBsu]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [HBsu]-L-lysine | Bacillus subtilis 168 | essential histone-like protein HBsu contains seven acetylation sites in vivo, mutational analysis using mutants hbsK86Q, hbsK41Q, hbsK3Q, hbsK41R, and hbsK37R | CoA + [HBsu]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [protein]-L-lysine | Bacillus subtilis | - |
CoA + [protein]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [protein]-L-lysine | Bacillus subtilis 168 | - |
CoA + [protein]-N6-acetyl-L-lysine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Bacillus subtilis | O34536 | - |
- |
Bacillus subtilis 168 | O34536 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
additional information | YfmK does not acetylate itself | Bacillus subtilis |
Purification (Comment) | Organism |
---|---|
recombinant wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by heparin affinity chromatography | Bacillus subtilis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-CoA + AVDSVFDTILDALK | histone-like protein HBsu peptide | Bacillus subtilis | CoA + AVDSVFDTILDALKac | - |
? | |
acetyl-CoA + AVDSVFDTILDALK | histone-like protein HBsu peptide | Bacillus subtilis 168 | CoA + AVDSVFDTILDALKac | - |
? | |
acetyl-CoA + VPAFKPGK | histone-like protein HBsu peptide | Bacillus subtilis | CoA + VPAFKPGKac | - |
? | |
acetyl-CoA + [HBsu]-L-lysine | essential histone-like protein HBsu contains seven acetylation sites in vivo, mutational analysis using mutants hbsK86Q, hbsK41Q, hbsK3Q, hbsK41R, and hbsK37R | Bacillus subtilis | CoA + [HBsu]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [HBsu]-L-lysine | histone-like protein HBsu | Bacillus subtilis | CoA + [HBsu]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [HBsu]-L-lysine | essential histone-like protein HBsu contains seven acetylation sites in vivo, mutational analysis using mutants hbsK86Q, hbsK41Q, hbsK3Q, hbsK41R, and hbsK37R | Bacillus subtilis 168 | CoA + [HBsu]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [HBsu]-L-lysine | histone-like protein HBsu | Bacillus subtilis 168 | CoA + [HBsu]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [protein]-L-lysine | - |
Bacillus subtilis | CoA + [protein]-N6-acetyl-L-lysine | - |
? | |
acetyl-CoA + [protein]-L-lysine | - |
Bacillus subtilis 168 | CoA + [protein]-N6-acetyl-L-lysine | - |
? | |
additional information | quantification of HBsu acetylation by parallel reaction monitoring-tandem mass spectrometry | Bacillus subtilis | ? | - |
- |
|
additional information | quantification of HBsu acetylation by parallel reaction monitoring-tandem mass spectrometry | Bacillus subtilis 168 | ? | - |
- |
Synonyms | Comment | Organism |
---|---|---|
KAT | - |
Bacillus subtilis |
lysine acetyltransferase | - |
Bacillus subtilis |
Nepsilon-lysine acetyltransferase | - |
Bacillus subtilis |
YfmK | - |
Bacillus subtilis |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Bacillus subtilis |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
assay at | Bacillus subtilis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
acetyl-CoA | - |
Bacillus subtilis |
General Information | Comment | Organism |
---|---|---|
malfunction | the compaction phenotype of the yfmK deletions is partially bypassed by the hbsK41Q allele. This partial bypass may be explained by the action of more than one acetyltransferase at K41 or that YfmK acts at multiple sites. YfmK also acts at K3, K18, and K80, while YdgE may also act at K86 | Bacillus subtilis |
additional information | characterization of the Bacillus subtilis acetylome | Bacillus subtilis |
physiological function | at least one physiological function of the acetylation of HBsu at key lysine residues by lysine acetyltransferase YfmK is to regulate nucleoid compaction, analogous to the role of histone acetylation in eukaryotes. Acetylation is a regulatory component of the function of HBsu in nucleoid compaction. HBsu belongs to the highly conserved HU family of nucleoid-associated proteins (NAPs) and is essential for viability in Bacillus subtilis. In bacteria, the NAPs are largely responsible for chromosome compaction | Bacillus subtilis |